I  Virginia Biotechnology Center

http://www.vabiotech.com





     Office Locations:

800 E. Leigh St.
Richmond, VA 23219
Phone: 804-828-5390
Fax: 804-828-8566

 

Stages:

  • Seed


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Since 1995, nearly 70 companies have been started in the Virginia BioTechnology Center, the Park's life sciences incubator. Approximately one-quarter of those companies have been started with discoveries and technologies coming out of research at Virginia Commonwealth University (VCU), with the remaining companies being started by entrepreneurs and scientists from as far north as New York and as far south as Florida. The Center is equipped with 10 wet laboratory/office suites and 22 private offices for companies not needing a wet laboratory. All have access to common equipment, meeting rooms and other shared facilities such as copiers, fax machines, mailboxes and common reception. The labs have built-in benches, casework and hoods and office furnishings. All utilities including high-speed internet service are included in the rent for the labs and office.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Carrie Roth Interim President and CEO
    Joy P. Edgett Director of Finance and Human Resources
    Paul F. Rocheleau Chairman & Chief Investment Officer
    William H. Daughtrey Executive Director
    William P. Dickinson Chief of Staff

     

    Portfolio companies include:


      Bill Police
        web link


      BluePrint Genomics
        web link


      Castle Technologies
        web link


      CellPoint Diagnostics
        web link


      Chicks With Kidz
        web link


      Cholabris
        web link


      Kinakeet Biotechnology
        web link


      Life for Kids
        web link


      Molecules for Health
        web link


      New Life Innovations
        web link


      Obetech
        web link


      Respiratory Drug Delivery and RDD Online
        web link


      Signal Processing Technologies
        web link


      Solveritas
        web link


      Zynnovation
        web link


     

    Recent News: